These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 31162642)
1. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia. Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT J Am Geriatr Soc; 2019 Sep; 67(9):1871-1879. PubMed ID: 31162642 [TBL] [Abstract][Full Text] [Related]
2. Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia. Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Hanson LC; Nace D; Thorpe JM; Thorpe CT J Am Geriatr Soc; 2020 Apr; 68(4):699-707. PubMed ID: 31769507 [TBL] [Abstract][Full Text] [Related]
3. Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing. Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT Alzheimers Dement; 2020 Apr; 16(4):630-640. PubMed ID: 32052930 [TBL] [Abstract][Full Text] [Related]
4. Anticholinergic co-prescribing in nursing home residents using cholinesterase inhibitors: Potential deprescribing cascade. Gromek KR; Thorpe CT; Aspinall SL; Hanson LC; Niznik JD J Am Geriatr Soc; 2023 Jan; 71(1):77-88. PubMed ID: 36206324 [TBL] [Abstract][Full Text] [Related]
5. Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia. Niznik JD; Aspinall SL; Hanson LC; Gilliam MA; Li X; Kelley CJ; Thorpe CT Osteoporos Int; 2022 Feb; 33(2):379-390. PubMed ID: 34480586 [TBL] [Abstract][Full Text] [Related]
6. Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission. Maclagan LC; Bronskill SE; Guan J; Campitelli MA; Herrmann N; Lapane KL; Hogan DB; Amuah JE; Seitz DP; Gill SS; Maxwell CJ J Am Med Dir Assoc; 2018 Nov; 19(11):959-966.e4. PubMed ID: 30262440 [TBL] [Abstract][Full Text] [Related]
7. Discontinuation of Statins in Veterans Admitted to Nursing Homes near the End of Life. Thorpe CT; Sileanu FE; Mor MK; Zhao X; Aspinall S; Ersek M; Springer S; Niznik JD; Vu M; Schleiden LJ; Gellad WF; Hunnicutt J; Thorpe JM; Hanlon JT J Am Geriatr Soc; 2020 Nov; 68(11):2609-2619. PubMed ID: 32786004 [TBL] [Abstract][Full Text] [Related]
8. Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia. Niznik J; Colón-Emeric C; Thorpe CT; Kelley CJ; Gilliam M; Lund JL; Hanson LC J Gen Intern Med; 2023 Nov; 38(15):3372-3380. PubMed ID: 37369891 [TBL] [Abstract][Full Text] [Related]
9. Incidence and Predictors of Aspirin Discontinuation in Older Adult Veteran Nursing Home Residents at End of Life. Springer SP; Mor MK; Sileanu F; Zhao X; Aspinall SL; Ersek M; Niznik JD; Hanlon JT; Hunnicutt J; Gellad WF; Schleiden LJ; Thorpe JM; Thorpe CT J Am Geriatr Soc; 2020 Apr; 68(4):725-735. PubMed ID: 32052858 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes. Vu M; Sileanu FE; Aspinall SL; Niznik JD; Springer SP; Mor MK; Zhao X; Ersek M; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM; Thorpe CT J Am Med Dir Assoc; 2021 Jan; 22(1):132-140.e5. PubMed ID: 32723537 [TBL] [Abstract][Full Text] [Related]
12. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease. Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047 [TBL] [Abstract][Full Text] [Related]
13. Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008. Palmer JB; Albrecht JS; Park Y; Dutcher S; Rattinger GB; Simoni-Wastila L; Walker LD; Zuckerman IH Drugs Aging; 2015 Jan; 32(1):79-86. PubMed ID: 25491558 [TBL] [Abstract][Full Text] [Related]
14. Statin Discontinuation and Life-Limiting Illness in Non-Skilled Stay Nursing Homes at Admission. Mack DS; Baek J; Tjia J; Lapane KL J Am Geriatr Soc; 2020 Dec; 68(12):2787-2796. PubMed ID: 33270223 [TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study. Havreng-Théry C; Oquendo B; Zolnowski-Kolp V; Krolak-Salmon P; Bertin-Hugault F; Lafuente-Lafuente C; Belmin J Alzheimers Res Ther; 2024 May; 16(1):117. PubMed ID: 38812028 [TBL] [Abstract][Full Text] [Related]
16. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia. Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360 [TBL] [Abstract][Full Text] [Related]
17. Statin discontinuation in nursing home residents with advanced dementia. Tjia J; Cutrona SL; Peterson D; Reed G; Andrade SE; Mitchell SL J Am Geriatr Soc; 2014 Nov; 62(11):2095-101. PubMed ID: 25369872 [TBL] [Abstract][Full Text] [Related]
18. Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer Disease. San-Juan-Rodriguez A; Zhang Y; He M; Hernandez I JAMA Netw Open; 2019 Mar; 2(3):e190213. PubMed ID: 30821828 [TBL] [Abstract][Full Text] [Related]
19. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis. Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262 [TBL] [Abstract][Full Text] [Related]
20. Frailty and Potentially Inappropriate Medication Use at Nursing Home Transition. Maclagan LC; Maxwell CJ; Gandhi S; Guan J; Bell CM; Hogan DB; Daneman N; Gill SS; Morris AM; Jeffs L; Campitelli MA; Seitz DP; Bronskill SE J Am Geriatr Soc; 2017 Oct; 65(10):2205-2212. PubMed ID: 28752589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]